Compound Detail
CHEMBL709
ALFUZOSIN 💊 Approved Drug
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
💊 Approved Drug
Basic Information
| ChEMBL ID | CHEMBL709 |
| Name | ALFUZOSIN |
| Phase | Approved |
| Structure Type | MOL |
| InChI Key | WNMJYKCGWZFFKR-UHFFFAOYSA-N |
| Therapeutic | ✓ Yes |
13
Targets
27
Activities
3
Assay Types
3
PK Parameters
20
Publications
4
Known Names
7
Indications
Molecular Properties
389.5
MW (Da)
1.35
ALogP
8
HBA
2
HBD
111.8
PSA (Ų)
0.65
QED
0
Ro5 Violations
8
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| First Approval | 2003 |
| Availability | Prescription |
| Chirality | Racemic |
Indications
Prostatic Hyperplasia Kidney Calculi Prostatitis Urinary Bladder, Neurogenic Urinary Retention Constipation Multiple Sclerosis
ATC Classification
G04CA01
alfuzosin
Level 1: GENITO URINARY SYSTEM AND SEX HORMONES
Level 2: UROLOGICALS
Activity Summary
IC50 11 meas. best 7.75
Ki 9 meas. best 8.55
Kd 7 meas. best 8.31
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Alpha-1B adrenergic receptor CHEMBL232 | Ki | 8.55 | 8.1567 | 2.8 | 3 |
| Alpha-1D adrenergic receptor CHEMBL223 | Ki | 8.5 | 8.47 | 3.2 | 2 |
| Alpha-1D adrenergic receptor CHEMBL326 | Ki | 8.46 | 8.46 | 3.5 | 1 |
| Alpha-1B adrenergic receptor CHEMBL315 | Kd | 8.31 | 8.31 | 4.9 | 1 |
| Rattus norvegicus CHEMBL376 | Kd | 8.31 | 7.96 | 4.9 | 2 |
| Alpha-1A adrenergic receptor CHEMBL229 | Ki | 8.09 | 8.045 | 8.2 | 2 |
| Acetylcholinesterase CHEMBL220 | IC50 | 7.75 | 7.75 | 18.0 | 1 |
| Adrenergic receptor alpha-1 CHEMBL2094251 | IC50 | 7.64 | 7.64 | 23.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL4892 | Ki | 7.64 | 7.64 | 23.0 | 1 |
| Alpha-1A adrenergic receptor CHEMBL319 | Kd | 7.61 | 7.61 | 24.6 | 1 |
| Canis familiaris CHEMBL373 | Kd | 6.87 | 6.765 | 134.9 | 2 |
| Alpha-1A adrenergic receptor CHEMBL229 | Kd | 6.66 | 6.66 | 218.8 | 1 |
| Voltage-gated inwardly rectifying potassium channel KCNH2 CHEMBL240 | IC50 | 4.9 | 4.8 | 12589.2 | 2 |
| Solute carrier family 22 member 1 CHEMBL5685 | IC50 | 4.83 | 4.83 | 14870.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| CL | 5.9 | mL.min-1.kg-1 | Homo sapiens |
| MRT | 4.2 | hr | Homo sapiens |
| T1/2 | 4.8 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine